InfuSystem (INFU) Competitors $8.96 -0.06 (-0.67%) (As of 09:48 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends INFU vs. OFIX, IRMD, KIDS, SRDX, SIBN, TMCI, TCMD, RCEL, CVRX, and DCTHShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Orthofix Medical (OFIX), Iradimed (IRMD), OrthoPediatrics (KIDS), Surmodics (SRDX), SI-BONE (SIBN), Treace Medical Concepts (TMCI), Tactile Systems Technology (TCMD), AVITA Medical (RCEL), CVRx (CVRX), and Delcath Systems (DCTH). These companies are all part of the "surgical & medical instruments" industry. InfuSystem vs. Orthofix Medical Iradimed OrthoPediatrics Surmodics SI-BONE Treace Medical Concepts Tactile Systems Technology AVITA Medical CVRx Delcath Systems Orthofix Medical (NASDAQ:OFIX) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, media sentiment, earnings, analyst recommendations and profitability. Which has more risk & volatility, OFIX or INFU? Orthofix Medical has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Do institutionals and insiders hold more shares of OFIX or INFU? 89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 2.6% of Orthofix Medical shares are held by company insiders. Comparatively, 10.2% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer OFIX or INFU? Orthofix Medical received 407 more outperform votes than InfuSystem when rated by MarketBeat users. However, 100.00% of users gave InfuSystem an outperform vote while only 61.92% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformOrthofix MedicalOutperform Votes41361.92% Underperform Votes25438.08% InfuSystemOutperform Votes6100.00% Underperform VotesNo Votes Which has stronger earnings and valuation, OFIX or INFU? InfuSystem has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$746.64M0.97-$151.40M-$3.13-6.06InfuSystem$125.79M1.51$870K$0.06149.36 Do analysts recommend OFIX or INFU? Orthofix Medical presently has a consensus target price of $23.00, indicating a potential upside of 21.24%. InfuSystem has a consensus target price of $13.00, indicating a potential upside of 45.09%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts clearly believe InfuSystem is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00 Is OFIX or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Orthofix Medical's net margin of -15.18%. InfuSystem's return on equity of 2.78% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-15.18% -21.25% -13.29% InfuSystem 1.12%2.78%1.41% Does the media prefer OFIX or INFU? In the previous week, InfuSystem had 2 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for InfuSystem and 1 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.60 beat InfuSystem's score of 0.00 indicating that Orthofix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryInfuSystem beats Orthofix Medical on 14 of the 19 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$190.49M$4.43B$5.07B$19.90BDividend YieldN/A36.79%4.99%3.49%P/E Ratio149.3613.5789.5636.63Price / Sales1.5144.221,224.8017.98Price / Cash14.2852.2739.4521.28Price / Book3.435.776.974.58Net Income$870,000.00$13.76M$119.04M$985.06M7 Day Performance-0.44%-0.99%-1.78%0.51%1 Month Performance32.74%0.71%-3.59%1.13%1 Year PerformanceN/A51.46%31.64%24.80% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem1.6869 of 5 stars$8.96-0.7%$13.00+45.1%N/A$190.49M$125.79M149.36499OFIXOrthofix Medical1.3806 of 5 stars$18.97+0.5%$23.00+21.2%+74.4%$724.84M$746.64M0.001,634IRMDIradimed4.503 of 5 stars$52.95+1.7%$60.00+13.3%+21.3%$670.88M$65.56M35.67110KIDSOrthoPediatrics4.0997 of 5 stars$25.51+0.0%$40.00+56.8%-19.9%$617.85M$148.73M-20.73200SRDXSurmodics4.2188 of 5 stars$39.22+0.1%$50.00+27.5%+12.2%$559.67M$126.08M0.00376SIBNSI-BONE4.3736 of 5 stars$12.14-0.1%$23.00+89.5%-32.6%$509.15M$138.89M0.00350Analyst ForecastInsider TradeAnalyst RevisionTMCITreace Medical Concepts1.0224 of 5 stars$7.86-1.5%$7.40-5.9%-7.1%$489.68M$187.12M0.00250TCMDTactile Systems Technology3.7846 of 5 stars$15.40-1.0%$23.00+49.4%+23.1%$369.60M$274.42M23.94980RCELAVITA Medical1.4051 of 5 stars$12.99-0.5%$16.50+27.0%+4.1%$340.60M$50.14M0.00130CVRXCVRx2.1065 of 5 stars$13.48-0.3%$15.83+17.5%-25.8%$327.03M$39.29M0.00200DCTHDelcath Systems3.5248 of 5 stars$9.90+2.8%$21.50+117.2%+256.7%$316.50M$2.07M0.0076 Related Companies and Tools Related Companies OFIX Competitors IRMD Competitors KIDS Competitors SRDX Competitors SIBN Competitors TMCI Competitors TCMD Competitors RCEL Competitors CVRX Competitors DCTH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:INFU) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
